Based on the Sensus Healthcare Inc stock forecast from 3 analysts, the average analyst target price for Sensus Healthcare Inc is USD 12.43 over the next 12 months. Sensus Healthcare Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Sensus Healthcare Inc is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, Sensus Healthcare Inc’s stock price was USD 4.46. Sensus Healthcare Inc’s stock price has changed by -0.67% over the past week, -2.83% over the past month and -24.79% over the last year.
No recent analyst target price found for Sensus Healthcare Inc
No recent average analyst rating found for Sensus Healthcare Inc
Company Overview Sensus Healthcare Inc
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida. Read Less
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT...Read More
Frequently Asked Questions About Sensus Healthcare Inc (SRTS) Stock
Based on ratings from 3 analysts Sensus Healthcare Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and hold ratings.
Unfortunately we do not have enough data on SRTS's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for SRTS is USD 12.43 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 10.
SRTS stock's Price/Earning ratio is 11.56.
Our analysis grades SRTS stock's Price / Earning ratio at F. This means that SRTS stock's Price/Earning ratio is above 48% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this SRTS may be fairly valued for its sector
The last closing price of SRTS's stock was USD 4.46.
The most recent market capitalization for SRTS is USD 0.08B.
Based on targets from 3 analysts, the average taret price for SRTS is projected at USD 12.43 over the next 12 months.
This means that SRTS's stock price may go up by +178.67% over the next 12 months.
We can't find any ETFs which contains Sensus Healthcare Inc's stock.
As per our most recent records Sensus Healthcare Inc has 54 Employees.
Sensus Healthcare Inc's registered address is 851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487.
You can get more information about it from Sensus Healthcare Inc's website at https://sensushealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Sensus Healthcare Inc (SRTS) Stock
Based on ratings from 3 analysts Sensus Healthcare Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and hold ratings.
Unfortunately we do not have enough data on SRTS's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for SRTS is USD 12.43 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 10.
SRTS stock's Price/Earning ratio is 11.56.
Our analysis grades SRTS stock's Price / Earning ratio at F. This means that SRTS stock's Price/Earning ratio is above 48% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this SRTS may be fairly valued for its sector
The last closing price of SRTS's stock was USD 4.46.
The most recent market capitalization for SRTS is USD 0.08B.
Based on targets from 3 analysts, the average taret price for SRTS is projected at USD 12.43 over the next 12 months.
This means that SRTS's stock price may go up by +178.67% over the next 12 months.
We can't find any ETFs which contains Sensus Healthcare Inc's stock.
As per our most recent records Sensus Healthcare Inc has 54 Employees.
Sensus Healthcare Inc's registered address is 851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487.
You can get more information about it from Sensus Healthcare Inc's website at https://sensushealthcare.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SRTS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
